approaches in oncology. Large combinatorial phage antibody libraries are available for the
identification of therapeutic antibodies and various technologies exist for their further
conversion into multivalent and multispecific formats optimized for the desired
pharmacokinetics and the pathological context. However, there is no technology for antigen
profiling of intact tumors to identify tumor markers targetable with antibodies. Such …